SCHEMBL22573633

SCHEMBL22573633

Cc1cccc(NC(=O)c2cnc(-c3ccccc3)nc2N)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 8/20 0.58
▸ KMT2A Q03164 8/20 0.58
▸ ALDH1A1 P00352 5/20 0.58
▸ LMNA P02545 5/20 0.58
▸ L3MBTL1 Q9Y468 2/20 0.58
▸ ATR Q13535 2/20 0.57
▸ SMN1; SMN2 Q16637 5/20 0.55
▸ MAPT P10636 4/20 0.55
▸ NPC1 O15118 2/20 0.55
▸ RAB9A P51151 2/20 0.55
▸ TP53 P04637 2/20 0.55
▸ NPSR1 Q6W5P4 3/20 0.53
▸ HTT P42858 2/20 0.53
▸ GAA P10253 2/20 0.52
▸ PKM P14618 1/20 0.52
▸ HPGD P15428 1/20 0.52
▸ KDM4E B2RXH2 1/20 0.52
▸ RXFP1 Q9HBX9 1/20 0.50
▸ KCNK3 O14649 1/20 0.50
▸ POLB P06746 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22573831 0.93 ATR (0.64) MEN1KMT2AALDH1A1LMNAL3MBTL1
SCHEMBL22573826 0.91 KCNK3 (0.53) MEN1KMT2AALDH1A1LMNAL3MBTL1
SCHEMBL22573589 0.89 IRAK4 (0.57) KMT2AATR
SCHEMBL22573719 0.86 LMNA (0.62) MEN1KMT2AALDH1A1LMNAL3MBTL1
SCHEMBL22573773 0.86 LMNA (0.62) MEN1KMT2AALDH1A1LMNAATR
SCHEMBL22573436 0.86 MEN1 (0.59) MEN1KMT2AALDH1A1LMNAL3MBTL1
SCHEMBL22573428 0.85 MEN1 (0.50) MEN1KMT2AALDH1A1LMNAL3MBTL1
SCHEMBL22573804 0.82 ATM (0.58) MEN1KMT2AALDH1A1LMNASMN1; SMN2
SCHEMBL22573661 0.81 RAB9A (0.54) MEN1KMT2AALDH1A1ATRSMN1; SMN2
SCHEMBL22573458 0.81 ATR (0.64) MEN1KMT2AALDH1A1LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3728236-A1 PYRIMIDINE DERIVATIVES AND THEIR USE USE FOR THE TREATMENT OF CANCER Adorx therapeutics Limited (GB) 2020-10-28 — — EP claimed
EP-3728236-A1 PYRIMIDINE DERIVATIVES AND THEIR USE USE FOR THE TREATMENT OF CANCER Adorx therapeutics Limited (GB) 2020-10-28 — — EP disclosed
Send feedback